Damian Garde

cv/@damiangarde

@statnews biotech reporter, inventor of CRISPR | damian.garde@statnews.com | Signal/WhatsApp: 202-780-9154

Categories
N/A
Content Types
N/A
More Information
Location|Languages
Publications

Published Content

25
Alzheimer's study sparks a new round of debate over the amyloid hypothesis
statnews.comArticle
Alzheimer's study sparks a new round of debate over the amyloid hypothesis
July, 30 2018
Experimental Alzheimer’s drug significantly slowed patients’ cognitive decline
statnews.comArticle
Experimental Alzheimer’s drug significantly slowed patients’ cognitive decline
July, 25 2018
FDA approves a game-changing treatment for blood cancer
statnews.comArticle
FDA approves a game-changing treatment for blood cancer
October, 18 2017
Pioneering cancer drug will cost $475,000. Analysts call it a bargain
statnews.comArticle
Pioneering cancer drug will cost $475,000. Analysts call it a bargain
August, 30 2017
FDA reverses course on drug developed by CEO with ties to Trump
statnews.comArticle
FDA reverses course on drug developed by CEO with ties to Trump
July, 11 2017
China rises as a biotech powerhouse, developing drugs to treat the world
statnews.comArticle
China rises as a biotech powerhouse, developing drugs to treat the world
June, 15 2017
How a drug ad made its way into 'General Hospital'
statnews.comArticle
How a drug ad made its way into 'General Hospital'
May, 18 2017
These five biotech CEOs earned big bucks even as their companies tanked
statnews.comArticle
These five biotech CEOs earned big bucks even as their companies tanked
May, 4 2017
Meet the lawyer trying to pry drug pricing secrets out of Big Pharma
statnews.comArticle
Meet the lawyer trying to pry drug pricing secrets out of Big Pharma
April, 20 2017
Who really wants to blow up the FDA? Not the drug industry
statnews.comArticle
Who really wants to blow up the FDA? Not the drug industry
February, 1 2017
Has the drug industry been cowed into silence by the tweeter-in-chief?
statnews.comArticle
Has the drug industry been cowed into silence by the tweeter-in-chief?
January, 31 2017
Top academics lash out at Trump's 'un-American' immigration ban
statnews.comArticle
Top academics lash out at Trump's 'un-American' immigration ban
January, 28 2017
Diabetes finding once heralded as breakthrough is retracted
statnews.comArticle
Diabetes finding once heralded as breakthrough is retracted
December, 27 2016
Alzheimer’s drug fails in late-stage trial, dashing hopes
statnews.comArticle
Alzheimer’s drug fails in late-stage trial, dashing hopes
November, 23 2016
What does Donald Trump's win mean for science and medicine?
statnews.comArticle
What does Donald Trump's win mean for science and medicine?
November, 9 2016
Raising 'good' cholesterol doesn't reduce heart attack risk
statnews.comArticle
Raising 'good' cholesterol doesn't reduce heart attack risk
October, 31 2016
Alzheimer's drug trial could offer real hope — or crush it
statnews.comArticle
Alzheimer's drug trial could offer real hope — or crush it
October, 13 2016
Inside Moderna Therapeutics, biotech's most secretive startup
statnews.comArticle
Inside Moderna Therapeutics, biotech's most secretive startup
September, 13 2016
Controversial CEO in the hot seat over EpiPen price hikes
statnews.comArticle
Controversial CEO in the hot seat over EpiPen price hikes
August, 24 2016
How biotech executives profit from legal insider trading
statnews.comArticle
How biotech executives profit from legal insider trading
August, 8 2016
The cure for ‘bubble boy’ disease will cost $665,000
statnews.comArticle
The cure for ‘bubble boy’ disease will cost $665,000
August, 3 2016
An ex-con takes indebted biotech Kadmon public, raising eyebrows
statnews.comArticle
An ex-con takes indebted biotech Kadmon public, raising eyebrows
July, 26 2016
FDA lets cancer trial resume after three patient deaths
statnews.comArticle
FDA lets cancer trial resume after three patient deaths
July, 12 2016
Juno halts immunotherapy trial for cancer after patient deaths
statnews.comArticle
Juno halts immunotherapy trial for cancer after patient deaths
July, 7 2016
Could a molecular 'agony switch' lead to a safer painkiller?
statnews.comArticle
Could a molecular 'agony switch' lead to a safer painkiller?
July, 5 2016
Authorship Stats
1Sites25Projects25,570Words
About
Damian Garde is a writer who has produced content for statnews.com
Key Phrases
Drug Industry, Drug Administration, Clinical Trial, Eli Lilly, Drug Companies, Gene Therapy, Patient Deaths, Wall Street, Biotech Company, Drug Makers
PrivacyContact UsSupport
© ClearVoice, Inc.